Sorry we missed you at the World Vaccine Congress in DC this April (2023). As previously mentioned, we showcased our poster providing information on the efficacy of LNP-mRNA using Sars-Cov-2 spike protein to demonstrate. We encourage you to download our…
By Julia Sakamoto, Marketing Specialist The development of mRNA vaccines has been ongoing since the late 80s, but it wasn’t until the COVID-19 pandemic that this technology became widely recognized. Instead of using an antigen to trigger the body’s immune…
Vernal’s mission has always been to democratize access to mRNA. One of the ways we are achieving this is expanding our capabilities in mRNA process and development so that we can provide GMP for clinical use cases. Take a look…
Didn’t have a chance to attend the 2022 mRNA Health Conference and talk about mRNA manufacturing needs for your projects? Download a copy of our poster regarding the “Design, formulation, and manufacturing of LNP-mRNA for clinically relevant applications” authored by…
Vernal’s mRNA platform manufacturing capabilities have gotten the attention of the mRNA community. Read Pharma’s Almanac’s expose on Vernal here: Platform Processes and End-to-End Capabilities Position Vernal Biosciences as a Critical CDMO Resource for mRNA Developers (pharmasalmanac.com)
Seven Days wrote a great follow up article on Vernal’s growth since the summer of 2021. Click the link below to see what we’ve been up to. What a difference a year makes! New Companies Are Riding Vermont’s Health Tech…
Vernal is proud to be the Silver Sponsor for this exciting event! Connect with one of Vernal’s experts on November 8-10, 2022 in Boston and meet them at our booth. We want to know about your mRNA and LNP projects,…
Vernal Biosciences is excited to announce the start of construction on its new, 23,000 square foot mRNA manufacturing facility in Essex Junction, Vt. The new facility will include state-of-the-art equipment and clean rooms to support clinical mRNA and LNP mRNA…
Local NBC affiliate NBC5 came to visit Vernal Bioscience to discuss the eventual move to a new, larger facility in Essex and our plans to nearly quadruple our workforce. Watch the story on NBC5.
Vernal produces high-purity mRNA to supply to companies that develop mRNA-based health treatments. Read the full story at VTDigger.